Characterizing CRISPR-Cas9 Experiments | Eclipsebio

Characterizing CRISPR-Cas9 Experiments

Upcoming

Virtual Webinar

CRISPR-Cas9 holds incredible promise for treating thousands of genetic disorders—but ensuring these therapies are both potent and safe is a major challenge. Join us for an in-depth webinar from Active Motif and Eclipsebio, where we break down the latest sequencing-based strategies for thoroughly characterizing CRISPR-Cas9.
Dr. Wayne Doyle, Head of Platform at Eclipsebio, will showcase how our eMERGE platform delivers actionable insights into impurities and therapeutic potency and Dr. Katelyn Mortenson, Epigenetics Services Scientist from Active Motif, will demonstrate how their DISCOVER-Seq assay precisely maps off-target editing events.
Don’t miss this opportunity to learn from the best in the field. Register now to secure your spot!

Summary

Dates:

February 20, 2025

Location:

Virtual

Topics:

CRISPR characterization

Share